Compare NetEase Inc (NTES) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs 10X Genomics Inc — how do they compare? NetEase Inc trades at $123.19 (market cap $82.75B), while 10X Genomics Inc trades at $59.23 (market cap $7.61B). The key difference: NetEase Inc is far larger — about 10.9× 10X Genomics Inc's market cap, and NetEase Inc pays a 2.36% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| NTES | TXG | |
|---|---|---|
Market Cap | $82.75B | $7.61B |
Sector | Media | Health |
52-Week High | $159.34 | $58.57 |
52-Week Low | $109.26 | $11.34 |
Enterprise Value | $59.05B | $7.14B |
Dividend Yield | 2.36% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
